- We are the Pharma Journal directory
Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice,...
Gene therapy is moving from specialist promise to established practice in 2025. Approvals have broadened across indications, clinical data in Huntington’s disease have shifted expectations...
For acute pain, time matters. Patients with postoperative dental pain, primary dysmenorrhoea, tension-type headache or migraine want relief that begins quickly and remains reliable. Ibuprofen...
Calciphylaxis, also termed calcific uremic arteriolopathy, is uncommon yet catastrophic. Small and medium dermal arterioles mineralise and thrombose, tissue perfusion collapses, and exquisitely painful lesions...
Isopropyl alcohol (IPA) remains a critical solvent and intermediate in various industries, including healthcare, personal care, and electronics. Analyst estimates diverge on headline size, yet...
A single figure can sway a submission or a clinical decision. When continuous data are grouped with unequal intervals, a simple count by bin exaggerates...
Huntington’s disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or...
A familiar antibiotic has crossed an ocean with an unfamiliar name. In April 2024 the U.S. Food and Drug Administration approved Pivya pivmecillinam for uncomplicated...
Five years after the acute waves of COVID-19, Long COVID has settled into public health planning as a common post-infectious condition with sustained clinical, economic...
Nitazenes are highly potent synthetic opioids from the benzimidazole family that now present a fast-moving threat in the United Kingdom and in other regions. The...